DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20192881

Seroprevalence of syphilis in human immunodeficiency virus patients

N. Lakshmi, K. Prasanthi, P. Kamala, C. Siva Kalyani, P. Appa Rao, B. Gowtham

Abstract


Background: Syphilis is a sexually transmitted infection caused by, Treponema pallidum. Syphilis facilitates the transmission and acquisition of human immunodeficiency virus (HIV) and causes transient increase in the viral load. Sexually transmitted infections (STI) are 3-5 times more likely to acquire HIV infection, if exposed to the virus through sexual contact. Aim of the study was to estimate the seroprevalence of Syphilis in HIV patients.

Methods: A total of 920 blood samples were collected from HIV patients attending ART (Antiretroviral therapy) centre and were tested for Syphilis by using Rapid Plasma Reagin (RPR) and Treponema pallidum Hemagglutination Assay (TPHA). A total of 100 HIV non-reactive individuals were taken as a control group.

Results: Out of 920 samples, 102 (11.1%) were positive for Syphilis. Out of 102 Syphilis seropositive patients, males (76.5%) were more commonly affected in age group of 21-40 years. Both RPR and TPHA were reactive in 46% of cases and only TPHA reactive in 53.9% of cases. Out of 100 HIV non-reactive patients, 5% of patients are reactive for Syphilis.

Conclusions: In the present study, prevalence of Syphilis was more in HIV patients compared to HIV non-reactive persons. Persons with HIV infection acquired through sexual route should be screened for Syphilis by one nonspecific test along with specific test to confirm the diagnosis. This will help in proper management of the patients having Syphilis and HIV co-infection.


Keywords


HIV, RPR, Syphilis, TPHA

Full Text:

PDF

References


Botham SJ, Ressler KA, Bourne C, Ferson MJ. Epidemic infectious syphilis in inner Sydney–strengthening enhanced surveillance. Aus N Z J Public Health. 2006;30(6):529-33.

Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates, 2001. Available at: https://www.who.int/reproductivehealth/publications/rtis/HIV_AIDS_2001_2/en/ . Accessed 28 May 2019.

Darrow WW, Echenberg DF, Jaffe HW, O'Malley PM, Byers RH, Getchell JP, et al. Risk factors for human immunodeficiency virus (HIV) infections in homosexual men. Am J Public Health. 1987;77(4):479-83.

Risk factors for AIDS among Haitians residing in the United States. Evidence of heterosexual transmission. The Collaborative Study Group of AIDS in Haitian-Americans. JAMA. 1987 Feb 6;257(5):635-9.

HIV InSite. Syphilis and HIV. 2006. Available at http://hivinsite.ucsf.edu/InSite?page=kb-05-01-04. Accessed 28 May 2019

Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, Bolan G, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med. 1997;337(5):307-14.

Royce RA, Sena A, Cates Jr W, Cohen MS. Sexual transmission of HIV. N Engl J Med. 1997;336(15):1072-8.

Tsang RS, Martin IE, Lau A, Sawatzky P. Serological diagnosis of syphilis: comparison of the Trep-Chek IgG enzyme immunoassay with other screening and confirmatory tests. FEMS Immunol Med Microbiol. 2007;51(1):118-24.

Löwhagen GB. Syphilis: test procedures and therapeutic strategies. Seminars Dermatol. 1990;9(2):152-9.

Salado-Rasmussen K. Syphilis and HIV co-infection. Epidemiology, treatment and molecular typing of Treponema pallidum. Dan Med J. 2015 1;62(12):B5176.

Gordon SM, Eaton ME, George R, Larsen S, Lukehart SA, Kuypers J, et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med. 1994;331(22):1469-73.

Kofoed K, Gerstoft J, Mathiesen LR, Benfield T. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sexually Transmit Dis. 2006;33(3):143-8.

Gitaí LL, Jaláli PS, Takayanagui OM. Neurosyphilis in the age of AIDS: clinical and laboratory features. Neurological Sci. 2009;30(6):465.

Sharma S, Chaudhary J, Hans C. VDRL v/s TPHA for diagnosis of syphilis among HIV sero-reactive patients in a tertiary care hospital. Int J Curr Microbiol App Sci. 2014;3(5):726-30.

Ray K, Bala M, Gupta SM, Khunger N, Puri P, Muralidhar S, et al. Changing trends in sexually transmitted infections at a Regional STD Centre in north India. Indian J Med Res. 2006;124(5):559-68.

Bala K, Chaudhary U, Gill PS, Mittal S, Vohra P. Seroprevalence of syphilis in HIV patients. Int J Pharm Med Bio Sci. 2013;2(1):38-44.

Eticha BT, Sisay Z, Alemayehu A. Seroprevalance of syphilis among HIV-infected individuals in Addis Ababa, Ethiopia: a hospital based cross-sectional study. BMJ Open. 2013;3:e002293.

Murawala SM, Vegad MM, Chudasama VC, Priyadarshini G, Gandhi PV. Seroprevalence and comparative study of diagnostic tests in syphilis in tertiary care teaching hospital, Western India. J Res Med Den Sci. 2015;3(3):199-203.

Dumre SP, Shakya G, Acharya D, Malla S, Adhikari N. Diagnostic dilemma of the single screening test used in the diagnosis of Syphilis in Nepal. Nepal Med Coll J. 2011;13(4):238-40.

Turbadkar D, Mathur M, Gaikwad S. Prevalence of Syphilis among HIV-seroreactive Patients. Indian J Sexually Transmitted Dis AIDS. 2007;28(2):91-3.

Young H, Henrichsen C. Treponema pallidum haemagglutination test as a screening procedure for the diagnosis of Syphilis. Brit J Veneral Dis. 1974;50(5):341-6.